ALKINDI

This brand name is authorized in Austria, Croatia, Estonia, Ireland, Israel, Lithuania, Poland, Romania, UK.

Active ingredients

The drug ALKINDI contains one active pharmaceutical ingredient (API):

1	Hydrocortisone UNII WI4X0X7BPJ - HYDROCORTISONE
	Hydrocortisone is the main glucocorticoid secreted by the adrenal cortex. Hydrocortisone is an anti-inflammatory steroid. Its anti-inflammatory action is due to reduction in the vascular component of the inflammatory response and reduction in the formation of inflammatory fluid and cellular exudates.
	Read more about Hydrocortisone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ALKINDI Granule in capsule	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H02AB09	Hydrocortisone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1764525, 1764536, 1764547, 1764558
GB	Medicines & Healthcare Products Regulatory Agency	356978, 356995, 357001, 357005
IL	מִשְׂרַד הַבְּרִיאוּת	9082, 9083, 9084, 9085
LT	Valstybinė vaistų kontrolės tarnyba	1085086, 1085087, 1085088, 1085089
PL	Rejestru Produktów Leczniczych	100402072, 100402089, 100402095, 100402103
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68176001, W68177001, W68178001, W68179001